- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
MassBio Releases Digital Health Study for Massachusetts
The Massachusetts Biotechnology Council (MassBio) announced the release of its recent digital health report, Making Massachusetts a Leading Global Destination for Digital Health. The report, which was done by Deloitte, looks at the current state of the digital health industry in Massachusetts, challenges facing its growth, and opportunities the state has to lead.
The study also identified at least three key opportunities where Massachusetts stakeholders could invest time and resources to drive growth and differentiation of its digital health ecosystem These include, but are not limited to: fostering better access to data and patients; developing a workforce that is able to tackle complex healthcare challenges through digital technology; and better coordinating the digital health entrepreneur and investor ecosystems. In addition to advocating for what the state can do, MassBio plans to launch new initiatives to support digital health entrepreneurs.
To read or download the full report, visit here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
